Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 17.84
-0.12 (-0.67%)
Sep 10, 2026, 2:09 PM CST
SHE:300119 Revenue
Tianjin Ringpu Bio-Technology had revenue of 894.33M CNY in the quarter ending June 30, 2026, with 0.94% growth. This brings the company's revenue in the last twelve months to 3.41B, up 1.50% year-over-year. In the year 2025, Tianjin Ringpu Bio-Technology had annual revenue of 3.40B with 10.70% growth.
Revenue (ttm)
3.41B
Revenue Growth
+1.50%
P/S Ratio
2.39
Revenue / Employee
1.22M
Employees
2,803
Market Cap
8.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.40B | 328.53M | 10.70% |
| Dec 31, 2024 | 3.07B | 360.83M | 13.32% |
| Dec 31, 2023 | 2.71B | 624.85M | 29.98% |
| Jan 1, 2023 | 2.08B | 77.11M | 3.84% |
| Jan 1, 2022 | 2.01B | 6.73M | 0.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.